These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 12220762
1. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy. Mount SL, Wegner EK, Eltabbakh GH, Olmstead JI, Drejet AE. Obstet Gynecol; 2002 Sep; 100(3):445-50. PubMed ID: 12220762 [Abstract] [Full Text] [Related]
3. Clinical relevance of benign endometrial cells in postmenopausal women. Ashfaq R, Sharma S, Dulley T, Saboorian MH, Siddiqui MT, Warner C. Diagn Cytopathol; 2001 Oct; 25(4):235-8. PubMed ID: 11599107 [Abstract] [Full Text] [Related]
4. The value of outpatient hysteroscopy in diagnosing endometrial pathology in postmenopausal women with and without hormone replacement therapy. Elliott J, Connor ME, Lashen H. Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1112-9. PubMed ID: 14616256 [Abstract] [Full Text] [Related]
5. Classification of benign endometrial glandular cells in cervical smears from postmenopausal women. Brogi E, Tambouret R, Bell DA. Cancer; 2002 Apr 25; 96(2):60-6. PubMed ID: 11954022 [Abstract] [Full Text] [Related]
11. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers. Aslan DL, Crapanzano JP, Harshan M, Erroll M, Vakil B, Pirog EC. Gynecol Oncol; 2007 Oct 25; 107(1):86-93. PubMed ID: 17604086 [Abstract] [Full Text] [Related]
13. Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001. Simsir A, Carter W, Elgert P, Cangiarella J. Am J Clin Pathol; 2005 Apr 25; 123(4):571-5. PubMed ID: 15743742 [Abstract] [Full Text] [Related]
14. Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy. Montz FJ. Gynecol Oncol; 2001 Apr 25; 81(1):33-9. PubMed ID: 11277646 [Abstract] [Full Text] [Related]
15. Normal endometrial cells in Papanicolaou smears: prevalence in women with and without endometrial disease. Zucker PK, Kasdon EJ. Obstet Gynecol; 2001 May 25; 97(5 Pt 1):798-9. PubMed ID: 11354070 [No Abstract] [Full Text] [Related]
16. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas. Moatamed NA, Le LT, Levin MR, Govind R, Apple SK. Diagn Cytopathol; 2013 Apr 25; 41(4):335-41. PubMed ID: 22102567 [Abstract] [Full Text] [Related]
17. Age cutoff for reporting of benign-appearing endometrial cells in Papanicolaou specimens; should it be raised? A 10-year retrospective study from a large county hospital. Hinson S, Molberg K, Mir M, Flores M, Zheng W, Lucas E. J Am Soc Cytopathol; 2019 Apr 25; 8(2):78-83. PubMed ID: 31287423 [Abstract] [Full Text] [Related]